Terms: = Kidney tumors AND CEBPA, CEBP, 1050, C/EBP-alpha, P49715 AND Prognosis
6 results:
1. Impact of ileostomy in the adjuvant treatment and outcome of colon cancer.
Calderillo-Ruíz G; López-Basave HN; Muñoz-Montaño WR; Díaz-Romero MC; Carbajal-López B; Castillo-Morales C; Pérez-Yépez EA; Albarran-García A
Int J Colorectal Dis; 2023 Jun; 38(1):158. PubMed ID: 37261538
[TBL] [Abstract] [Full Text] [Related]
2. Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation: Clinicopathologic Correlation and Molecular Findings.
Gama A; Xu H; Yang XJ; Choy B
Int J Surg Pathol; 2024 Feb; 32(1):11-16. PubMed ID: 37063043
[No Abstract] [Full Text] [Related]
3. Percentage grade 4 tumour predicts outcome for clear cell renal cell carcinoma.
Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Varma M; Samaratunga H
Pathology; 2019 Jun; 51(4):349-352. PubMed ID: 30987774
[TBL] [Abstract] [Full Text] [Related]
4. GFOD1 and peejar are promising markers for clear-cell renal cell carcinoma disease progression.
Wu XR; Chen YH; Chen W; Kong W; Huang JW; Zhang J; Xue W; Liu DM; Huang YR
Oncotarget; 2016 Jun; 7(25):38004-38009. PubMed ID: 27191742
[TBL] [Abstract] [Full Text] [Related]
5. The evolution of treatment for Wilms tumor.
Green DM
J Pediatr Surg; 2013 Jan; 48(1):14-9. PubMed ID: 23331787
[TBL] [Abstract] [Full Text] [Related]
6. Long-term serial transplantation of 30 different human renal cell carcinomas into NMRI (nu/nu) mice: flow cytometric, histologic, and growth studies.
Baisch H; Otto U; Klöppel G
J Natl Cancer Inst; 1986 Feb; 76(2):269-76. PubMed ID: 2418248
[TBL] [Abstract] [Full Text] [Related]
